First published · Last updated
The monoacylglycerol acyltransferase 2 inhibitor VB-85387 reduces MASLD
A journal article published by Elsevier on 2026-10-01 reports that the MAGAT2 inhibitor VB-85387 reduces MASLD. No additional methodological, population, or outcome details were provided in the supplied source data.
Categories: science-and-space, public-health, positive-progress
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 5/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Positivity
- 6/10
- Urgency
- 2/10
Why it matters
The report describes a potential therapeutic effect against MASLD that could be relevant for medical research and treatment development.

